# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122817
Filing Date
2024-11-07
Accepted
2024-11-07 08:00:23
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | pmvp-20240930.htm iXBRL | 10-Q | 1721340
2 | EX-31.1 | pmvp-ex31_1.htm | EX-31.1 | 16876
3 | EX-31.2 | pmvp-ex31_2.htm | EX-31.2 | 16635
4 | EX-32.1 | pmvp-ex32_1.htm | EX-32.1 | 8878
5 | EX-32.2 | pmvp-ex32_2.htm | EX-32.2 | 9134
| Complete submission text file | 0000950170-24-122817.txt |  | 7331079

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | pmvp-20240930.xsd | EX-101.SCH | 1015837
72 | EXTRACTED XBRL INSTANCE DOCUMENT | pmvp-20240930_htm.xml | XML | 1270662

Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 241433267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)